ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2018

Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors.

Gary T Ferguson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.